Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)

Authors

Tina Grünfeld Eén
CHRISTINE A. PESCHKEN (ORCID: https://orcid.org/0000-0002-4269-5213)
Eric Francis Morand (ORCID: https://orcid.org/0000-0002-9507-3338)
Raj Tummala (ORCID: https://orcid.org/0000-0002-5506-4445)
Alberta Hoi (ORCID: https://orcid.org/0000-0002-9416-7383)
Bo Ding (ORCID: https://orcid.org/0000-0001-9131-4563)
Jonatan Hedberg (ORCID: https://orcid.org/0000-0001-9362-4020)
Richard Alan Furie (ORCID: https://orcid.org/0000-0001-6712-1585)
Stephanie Chen (ORCID: https://orcid.org/0000-0001-8074-2255)
Laurent Arnaud (ORCID: https://orcid.org/0000-0002-8077-8394)
Kai Wai Lee (ORCID: https://orcid.org/0009-0003-4888-7579)
Martin Aringer (ORCID: https://orcid.org/0000-0003-4471-8375)

Institutions

AstraZeneca (United Kingdom) (GB)
Manitoba Health (CA)
Hofstra University (US)
Inserm (FR)
AstraZeneca (Singapore) (SG)
AstraZeneca (Switzerland) (CH)
AstraZeneca (Japan) (JP)
AstraZeneca (Poland) (PL)
AstraZeneca (Italy) (IT)
AstraZeneca (Sweden) (SE)
University of Manitoba (CA)
Monash University (AU)
Université de Strasbourg (FR)
Technische Universität Dresden (DE)

Publication Details

Journal: Lara D. Veeken
Published: 2025-11-11
DOI: https://doi.org/10.1093/rheumatology/keaf599
Primary Topic: Systemic Lupus Erythematosus Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)

Tina Grünfeld Eén, CHRISTINE A. PESCHKEN, Eric Francis Morand, Raj Tummala et al.

Nov 11, 2025

Lara D. Veeken

Systemic Lupus Erythematosus Research

article

Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)

Tina Grünfeld Eén, CHRISTINE A. PESCHKEN, Eric Francis Morand, Raj Tummala, Alberta Hoi, Bo Ding, Jonatan Hedberg, Richard Alan Furie, Stephanie Chen, Laurent Arnaud, Kai Wai Lee, Martin Aringer

November 11, 2025article en

Abstract

No abstract available for this paper.

Lara D. VeekenVol. 65(2)

AstraZeneca (United Kingdom) (GB), Manitoba Health (CA), Hofstra University (US), Inserm (FR), AstraZeneca (Singapore) (SG), AstraZeneca (Switzerland) (CH), AstraZeneca (Japan) (JP), AstraZeneca (Poland) (PL), AstraZeneca (Italy) (IT), AstraZeneca (Sweden) (SE), University of Manitoba (CA), Monash University (AU), Université de Strasbourg (FR), Technische Universität Dresden (DE)

Openalex Percentile: Top 52%

Systemic Lupus Erythematosus Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS) — Tina Grünfeld Eén, CHRISTINE A. PESCHKEN, et al. · Lara D. Veeken (2025) | TGRS Research Map | TGRS